Sharechat Logo

Xero's cash burn accelerates as costs to grow run ahead of sales

Wednesday 31st July 2013

Text too small?

Xero, the cloud-based accounting firm, burned through more cash last quarter as the company's rapid expansion saw wages, advertising and marketing payments run ahead of sales.

The Wellington-based company's cash flow statement shows it was sitting on $68.8 million of cash as at June 30, down $9.4 million from three months earlier. It used $6.57 million in the first quarter of the year.

Xero is chasing sales growth in lieu of profits, with an aspirational target of 1 million customers worldwide, from 157,000 as at March 31.

In the latest quarter, receipts from customers rose to $12.97 million, from $11.4 million three months earlier. Staff costs climbed to $10 million from $6.9 million and advertising and marketing rose to $2.1 million from $881,000. That resulted in negative operating cash flow widening to $4.4 million from $2.5 million in the first quarter.

The company has ample cash to continue to pursue its growth plans. At the second-quarter burn rate, it could continue to fund its operations for at least seven more quarters without having to seek additional funding.

The shares slipped 1.1 percent to $17.31 on the NZX today and have soared 130 percent this year. It went public in 2007, selling shares in an initial public offering at $1 apiece.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors